{{Rsnum
|rsid=4900442
|Gene=CYP46A1
|Chromosome=14
|position=99691904
|Orientation=plus
|GMAF=0.4431
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CYP46A1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 27.4 | 50.4 | 22.1
| HCB | 27.3 | 52.3 | 20.5
| JPT | 18.6 | 49.6 | 31.9
| YRI | 51.7 | 42.9 | 5.4
| ASW | 38.6 | 45.6 | 15.8
| CHB | 27.3 | 52.3 | 20.5
| CHD | 20.4 | 54.6 | 25.0
| GIH | 20.8 | 50.5 | 28.7
| LWK | 47.2 | 43.5 | 9.3
| MEX | 15.8 | 49.1 | 35.1
| MKK | 48.1 | 39.7 | 12.2
| TSI | 26.7 | 50.5 | 22.8
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19286353
|Title=CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism
}}

{{PMID Auto
|PMID=16960449
|Title=Intron 2 (T/C) CYP46 polymorphism is associated with Alzheimer's disease in Chinese patients.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}